PharmaCONNECT ™

ORTHO-CYCLEN (28) (NORGESTIMATE-ETHINYL ESTRADIOL) by ORTHO PHARM.

ORTHO-CYCLEN (28) (NORGESTIMATE-ETHINYL ESTRADIOL) ORTHO PHARM.

Warning: Do not use if you are pregnant, suspect that you are pregnant, or while breastfeeding. Consult your doctor or pharmacist.

Some medications may cause hormonal birth control to work less well. Ask your doctor or pharmacist.

DO NOT SMOKE. Smoking combined with oral contraceptives causes a significant increase in the risk of serious heart and circulation problems.

If this medication upsets your stomach, take it with crackers, bread or a small meal.

It is very important that you take or use this exactly as directed. Do not skip doses or discontinue unless directed by your doctor.

Herbal/dietary supplement products may interact with this medication. Discuss any such product with your doctor or pharmacist before taking.

Use of this medication does not protect you or your partner against sexually transmitted diseases (e.g.,HIV,gonorrhea).

WARNING: Smoking cigarettes/using tobacco while using hormonal birth control (pill/patch/ring) increases your risk of heart problems and stroke. Do not smoke. The risk of heart problems increases with age (especially in women over 35) and with frequent smoking (15 or more cigarettes a day).

INDICATIONS:
Defective Internal Secretion of Ovaries
Disease of Ovaries with Cysts
Endometriosis
Painful Periods
Absence of Menstrual Periods
Abnormally Long or Heavy Periods
Abnormal Bleeding from the Uterus
Birth Control
Acne

CONTRAINDICATIONS:
ORAL CONTRACEPTIVES: Abnormal Hepatic Function Tests
ORAL CONTRACEPTIVES: Angina
ORAL CONTRACEPTIVES: Breast Carcinoma
ORAL CONTRACEPTIVES: Cerebrovascular Accident
ORAL CONTRACEPTIVES: Cholestasis of Pregnancy
ORAL CONTRACEPTIVES: Coronary Artery Disease
ORAL CONTRACEPTIVES: Deep Venous Thrombosis
ORAL CONTRACEPTIVES: Disease of Liver
ORAL CONTRACEPTIVES: Endometrial Carcinoma
ORAL CONTRACEPTIVES: Estrogen-Dependent Neoplasm
ORAL CONTRACEPTIVES: Major Surgery with Prolonged Post-Operative Immobilization
ORAL CONTRACEPTIVES: Malignant Neoplasm of Liver
ORAL CONTRACEPTIVES: Migraine
ORAL CONTRACEPTIVES: Myocardial Infarction
ORAL CONTRACEPTIVES: Obstructive Hyperbilirubinemia
ORAL CONTRACEPTIVES: Pregnancy
ORAL CONTRACEPTIVES: Pulmonary Thromboembolism
ORAL CONTRACEPTIVES: Severe Uncontrolled Hypertension
ORAL CONTRACEPTIVES: Thromboembolic Disorder
ORAL CONTRACEPTIVES: Thrombophlebitis
ORAL CONTRACEPTIVES: Valvular Heart Disease
ORAL CONTRACEPTIVES: Gallbladder Disease
ORAL CONTRACEPTIVES: Increased Cardiovascular Event Risk
ORAL CONTRACEPTIVES: Malignant Tumor of Cervix
ORAL CONTRACEPTIVES: Metrorrhagia
ORAL CONTRACEPTIVES: Obesity
ORAL CONTRACEPTIVES: Porphyria
ORAL CONTRACEPTIVES: Retinal Thrombosis
ORAL CONTRACEPTIVES: Tobacco Smoker
ORAL CONTRACEPTIVES: Benign Mammary Dysplasia
ORAL CONTRACEPTIVES: Body Fluid Retention
ORAL CONTRACEPTIVES: Depression
ORAL CONTRACEPTIVES: Diabetes Mellitus
ORAL CONTRACEPTIVES: Hypercholesterolemia
ORAL CONTRACEPTIVES: Hyperglycemia
ORAL CONTRACEPTIVES: Hyperlipidemia
ORAL CONTRACEPTIVES: Hypertension
ORAL CONTRACEPTIVES: Hypertriglyceridemia
ORAL CONTRACEPTIVES: Nonspecific Abnormal Papanicolaou Smear of Cervix

MONOGRAPH - PATIENT:
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.

PROGESTIN/ESTROGEN CONTRACEPTIVE - ORAL (proe-JES-tin/ES-troe-jen)

WARNING: Smoking cigarettes/using tobacco while using hormonal birth control (pill/patch/ring) increases your risk of heart problems and stroke. Do not smoke. The risk of heart problems increases with age (especially in women over 35) and with frequent smoking (15 or more cigarettes a day).

USES: This combination hormone medication is used to prevent pregnancy. It contains 2 hormones: a progestin and an estrogen. These hormones prevent pregnancy in 3 ways. One way is by preventing the release of an egg (ovulation). A second way is by changing the cervical mucus, making it more difficult for an egg to meet sperm (fertilization). A third way is by changing the womb lining, making it difficult for a fertilized egg to attach to the lining of the womb (implantation). A fertilized egg (embryo/unborn baby) needs to attach to the womb to receive blood and nutrients and continue to grow. If an embryo/unborn baby does not attach, it cannot survive. Besides preventing pregnancy, birth control pills have been shown to help make your periods more regular, decrease blood loss and painful periods (dysmenorrhea), and decrease your risk of ovarian cysts. Use of this medication does not protect you or your partner against sexually transmitted diseases (e.g., HIV, gonorrhea, chlamydia).

HOW TO USE: Read the Patient Information Leaflet provided by your pharmacist before you start using this product and each time you get a refill. The leaflet contains very important information on when to take your pills and what to do if you miss a dose. If you have any questions, consult your doctor or pharmacist. Take this medication by mouth once daily or as directed by your doctor. Pick a time of day that is easy for you to remember, and take your pill at the same time each day. It is very important to continue taking this medication exactly as prescribed by your doctor. With certain brands of birth control pills, the amount of estrogen and progestin in each active tablet will vary at different times in the cycle. Therefore, it is very important that you follow the package instructions to find the first tablet, start with the first tablet in the pack, and take them in the correct order. Do not skip any doses. Pregnancy is more likely if you miss pills, start a new pack late, or take your pill at a different time of the day than usual. Taking this medication after your evening meal or at bedtime may help if you have stomach upset or nausea with the medication. You may choose to take this medication at another time of day that is easier for you to remember. No matter what dosing schedule you use, it is very important that you take this medication at the same time each day, 24 hours apart. Ask your doctor or pharmacist if you have any questions. Your pill pack contains 21 pills with active medication. It may also contain 7 reminder pills with no medication. Take one active pill (with hormones) once daily for 21 days in a row. If you are using a product with 28 tablets, take an inactive pill once daily for 7 days in a row after you have taken the last active pill unless otherwise directed by your doctor. If you are using a product with 21 tablets, do not take any tablets for 7 days unless otherwise directed by your doctor. You should have your period during the fourth week of the cycle. After you have taken the last inactive tablet in the pack or gone 7 days without taking an active tablet, start a new pack the next day whether or not you have your period. If you do not get your period, consult your doctor. If this is the first time you are using this medication and you are not switching from another form of hormonal birth control (e.g., patch, other birth control pills), take the first tablet in the pack on the first Sunday following the beginning of your menstrual period or on the first day of your period. If your period begins on a Sunday, begin taking this medication on that day. For the first cycle of use only, use an additional form of non-hormonal birth control (e.g., condoms, spermicide) for the first 7 days to prevent pregnancy until the medication has enough time to work. If you start on the first day of your period, you do not need to use back-up birth control the first week. Ask your doctor or pharmacist for information about how to switch from other forms of hormonal birth control (e.g., patch, other birth control pills) to this product. If any of this information is unclear, consult the Patient Information Leaflet or your doctor or pharmacist.

SIDE EFFECTS: Nausea, vomiting, headache, stomach cramping/bloating, dizziness, vaginal discomfort/irritation, increased vaginal fluids, or breast tenderness/enlargement may occur. Acne may improve or get worse. Vaginal bleeding between periods (spotting) or missed/irregular periods may occur, especially during the first few months of use. If any of these effects persist or worsen, notify your doctor promptly. If you miss 2 periods in a row (or 1 period if the pill has not been used properly), contact your doctor for a pregnancy test. Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects. Tell your doctor immediately if any of these serious side effects occur: changes in vaginal bleeding (e.g., continuous spotting, sudden heavy bleeding, missed periods), problem wearing contact lenses, dark patches on the skin (melasma), unwanted facial/body hair, swelling of the ankles/feet, weight changes (gain or loss). This medication may rarely cause serious (sometimes fatal) problems from blood clots (e.g., pulmonary embolism, stroke, heart attack). Seek immediate medical attention if you experience: sudden shortness of breath, chest/jaw/left arm pain, confusion, coughing up blood, sudden dizziness/fainting, pain/swelling/warmth in the groin/calf, tingling/weakness/numbness in the arms/legs, headaches that are different from those you may have experienced in the past (e.g., headaches with other symptoms such as vision changes/lack of coordination, existing migraines becoming worse, sudden/very severe headaches), slurred speech, weakness on one side of the body, vision problems/changes. Tell your doctor immediately if any of these rare but very serious side effects occur: lumps in the breast, severe stomach/abdominal/pelvic pain, mental/mood changes (e.g., depression, suicidal thoughts, persistent trouble sleeping), unusual tiredness, dark urine, yellowing eyes/skin. A very serious allergic reaction to this drug is unlikely, but seek immediate medical attention if it occurs. Symptoms of a serious allergic reaction include: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing. This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist. In the US - Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

PRECAUTIONS: See also Warning section. Before using this medication, tell your doctor or pharmacist if you are allergic to any estrogens (e.g., ethinyl estradiol, mestranol) or any progestins (e.g., norethindrone, desogestrel); or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details. This medication should not be used if you have certain medical conditions. Before using this product, consult your doctor or pharmacist if you have: history of stroke or other blood clots (e.g., in the legs, eyes, lungs), severe high blood pressure, abnormal breast exam, cancer (especially endometrial or breast cancer), diabetes that has caused kidney/eye/nerve/blood vessel disease, severe headaches, history of heart disease (e.g., heart attack, chest pain), heart valve disease, liver problems (e.g., liver tumor, active liver disease), current or suspected pregnancy, recent major surgery, long periods of sitting or lying down (e.g., immobility such as being bedridden), history of yellowing eyes/skin (jaundice) during pregnancy or while using hormonal birth control (e.g., pills, patch), unexplained vaginal bleeding, heavy tobacco use (especially if 35 or over). Before using this product, tell your doctor your medical history, especially of: high blood pressure, high cholesterol or triglyceride (blood fat) levels, depression, diabetes, swelling (edema), gallbladder problems, kidney disease, migraine, obesity, irregular/missed/very light periods, recent pregnancy, thyroid problems. Do not smoke cigarettes or use tobacco. Hormonal birth control (e.g., pills, injections, devices) combined with smoking significantly increases your risk for stroke, blood clots, high blood pressure, and heart attacks, especially in women older than 35. For more details, ask your doctor or pharmacist, or consult the Patient Information Leaflet that comes with this product. If you have diabetes, this medication may make it harder to control your blood sugar levels. Monitor your blood sugar regularly as directed by your doctor. Tell your doctor the results and any symptoms such as increased thirst/urination. Your anti-diabetic medication or diet may need to be adjusted. Notify your doctor beforehand if you will be having surgery or will be confined to a chair/bed for a long time (e.g., a long plane flight). You may need to stop the medication for a time or take special precautions. This medication may cause blotchy, dark areas on your skin (melasma). Sunlight may worsen this effect. Avoid prolonged sun exposure, sunlamps, and tanning booths. Use a sunscreen, and wear protective clothing when outdoors. If you are nearsighted or wear contact lenses, you may develop vision problems or trouble wearing your contact lenses. Contact your eye doctor if these problems occur. It may take longer for you to become pregnant after you stop taking birth control pills. Consult your doctor. This medication must not be used during pregnancy. If you become pregnant or think you may be pregnant, tell your doctor immediately. If you have just given birth or had a pregnancy loss/abortion after the first 3 months, talk with your doctor about reliable forms of birth control, and find out when it is safe to start using birth control that contains a form of estrogen, such as this medication. This medication passes into breast milk. This may affect milk production and may have undesirable effects on a nursing infant. Consult your doctor before breast-feeding.

DRUG INTERACTIONS: The effects of some drugs can change if you take other drugs or herbal products at the same time. This can increase your risk for serious side effects or may cause your medications not to work correctly. These drug interactions are possible, but do not always occur. Your doctor or pharmacist can often prevent or manage interactions by changing how you use your medications or by close monitoring. To help your doctor and pharmacist give you the best care, be sure to tell your doctor and pharmacist about all the products you use (including prescription drugs, nonprescription drugs, and herbal products) before starting treatment with this product. While using this product, do not start, stop, or change the dosage of any other medicines you are using without your doctor's approval. Some products that may interact with this drug include: aromatase inhibitors (e.g., anastrazole, exemestane), raloxifene, sodium tetradecyl sulfate, tamoxifen, medication for underactive thyroid (hypothyroidism), drugs that may increase blood levels of this drug (e.g., acetaminophen, ascorbic acid/vitamin C, atorvastatin, azole antifungals such as itraconazole/ketoconazole/vaginal miconazole). Some drugs may cause hormonal birth control to work less well by decreasing the amount of birth control hormones in your body. This effect can result in pregnancy. Examples include griseofulvin, modafinil, rifamycins (such as rifampin, rifabutin), St. John's wort, drugs used to treat seizures (such as barbiturates, carbamazepine, felbamate, phenytoin, primidone, topiramate), HIV drugs (such as nelfinavir, nevirapine, ritonavir), among others. Tell your doctor when you start any new drug, and discuss if you should use additional reliable birth control. Also tell your doctor if you have any new spotting or breakthrough bleeding, because these may be signs that your birth control is not working well. This drug can speed up or slow down the removal of other drugs from your body by affecting certain liver enzymes. These affected drugs include acetaminophen, aspirin, certain beta blockers (e.g., metoprolol), clofibrate, cyclosporine, morphine, corticosteroids such as prednisolone, certain benzodiazepines such as lorazepam/temazepam, and theophylline, among others. If you are currently using any of these medications listed above, tell your doctor or pharmacist before starting this medication. This medication can affect the results of certain lab tests (e.g., blood tests for clotting factors, thyroid). Make sure laboratory personnel and all your doctors know you use this medication. This document does not contain all possible drug interactions. Keep a list of all the products you use. Share this list with your doctor and pharmacist to lessen your risk for serious medication problems.

OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. Symptoms of overdose may include severe nausea and vomiting. Females may experience sudden/unusual vaginal bleeding.

NOTES: Do not share this medication with others. Keep all appointments with your doctor and the laboratory. You should have regular complete physical exams including blood pressure, breast exam, pelvic exam, and screening for cervical cancer (pap smear). Follow your doctor's instructions for examining your own breasts, and report any lumps immediately. Consult your doctor for more details.

MISSED DOSE: Missed dose advice is different depending on the brand used and the number of doses missed. Refer to the product package information for advice on missed doses. You may need to use back-up birth control (e.g., condoms, spermicide) to prevent pregnancy. Ask your doctor or pharmacist if you have any questions. If you often forget to take your pills as directed, contact your doctor to discuss switching to another form of birth control.

STORAGE: Store at room temperature between 59-86 degrees F (between 15-30 degrees C) away from light and moisture. Do not store in the bathroom. Keep all medicines away from children and pets. Do not flush medications down the toilet or pour them into a drain unless instructed to do so. Properly discard this product when it is expired or no longer needed. Consult your pharmacist or local waste disposal company for more details about how to safely discard your product.

Information last revised January 2011 Copyright(c) 2011 First DataBank, Inc.


MONOGRAPH - FOOD & DRUG:
MONOGRAPH TITLE: Estrogens/Grapefruit Juice Interaction

SIGNIFICANCE LEVEL: 3-Significant; Documented (more clinical data may be needed): Conservative measures are recommended until more is known.

MECHANISM OF ACTION: CYP P-450-3A4 and isoenzymes of CYP P-450-2C and P-450-Ce take part in 2-hydroxylation of ethinyl estradiol. In 2-hydroxylation of ethinyl estradiol, isoenzymes of CYP P-450-3A4(1) as well as CYP P-450-2C and CYO P-450-2E are involved.(2) Flavonoids present in grapefruit juice inhibit CYP P-450-3A4 greatly.(3) Thus, it is believed that naringin (a grapefruit flavonoid) or naringenin (its aglycon) prevent the 2-hydroxylation of ethinyl estradiol by inhibition of CYP P-450-3A4 in the gut. Grapefruit juice may affect other estrogens similarly.(5-7)

CLINICAL EFFECTS: Increases in estrogen serum concentrations.

PATIENT MANAGEMENT: Co-administration of grapefruit juice can lead to elevated estrogen levels. Since the extent of this interaction varies among subjects, monitoring of patients is recommended.

DISCUSSION: 13 healthy females participated in a randomized, cross-over study in order to determine the effects of grapefruit juice on exogenously administered ethinyl estradiol. The subjects were to stop using steroid contraceptives at least a month prior to this experiment. After an overnight fast, on day 411 of the menstrual cycle, each subject ingested 100 mL of either herbal tea or grapefruit juice (naringin concentration 887 mg/mL). Each subject received 0.05 mg of 17?-ethinyl estradiol with 100 mL of the initial corresponding fluid thirty minutes following the administration of first 100 mL of fluids. Then, the volunteers consumed 200 mL of corresponding fluid every three hours, up to four times on the day of the study. Blood samples obtained following administration of ethinyl estradiol, revealed that grapefruit juice increased maximum plasma concentration (Cmax) of ethinyl estradiol from 85 pg/mL to 117 pg/ml when compared to herbal tea (p = 0.009). The 0-6 hours and 0-8 areas-under-curve (AUC) also elevated significantly with p values of 0.0192 and 0.0186, respectively. The Cmax variability was -19% to +80% and the AUC (0-8 hours) was 16% to +114%.(4) In an open, randomized, cross-over study in 8 ovariectomized women, subjects received single doses of 2 mg micronized 17 beta-estradiol with and without grapefruit juice. Grapefruit juice increased peak and AUC estrone levels significantly.(5) Grapefruit juice was also found to inhibit 17 beta-estradiol metabolism in human liver microsomes.(6) Grapefruit juice may increase levels of conjugated estrogens as well.(7)

REFERENCES:

1.Guengerich FP. Oxidation of 17 alpha-ethynylestradiol by human liver cytochrome P-450. Mol Pharmacol 1988 May;33(5):500-8. 2.Ball SE, Forrester LM, Wolf CR, Back DJ. Differences in the cytochrome P-450 isoenzymes involved in the 2-hydroxylation of oestradiol and 17 alpha-ethinyloestradiol. Relative activities of rat and human liver enzymes. Biochem J 1990 Apr 1;267(1):221-6. 3.Miniscalco A, Lundahl J, Regardh CG, Edgar B, Eriksson UG. Inhibition of dihydropyridine metabolism in rat and human liver microsomes by flavonoids found in grapefruit juice. J Pharmacol Exp Ther 1992 Jun;261(3):1195-9. 4.Schubert W, Cullberg G, Edgar B, Hedner T. Inhibition of 17 beta-estradiol metabolism by grapefruit juice in ovariectomized women. Maturitas 1994 Dec;20(2-3):155-63. 5.Schubert W, Eriksson U, Edgar B, Cullberg G, Hedner T. Flavonoids in grapefruit juice inhibit the in vitro hepatic metabolism of 17 beta-estradiol. Eur J Drug Metab Pharmacokinet 1995 Jul-Sep;20(3):219-24. 6.Fingerova H, Oborna I, Petrova P, Budikova M, Jezdinsky J. Does grapefruit juice increase the bioavailability of orally administered sex steroids?. Ceska Gynekol 2003 Mar;68(2):117-21. 7.Premarin (conjugated estrogen tablets, USP) US prescribing information. Wyeth Pharmaceuticals Inc. April, 2005.

RELATED DISEASES:
Abnormal Uterine Bleeding
Acneiform Eruption
Acute Eruptions of Skin
Acute Hemorrhage
Amenorrhea
Bacterial Skin and Skin Structure Infection
Disorder of Skin
Endometrial Hyperplasia
Endometriosis
Female Hypogonadism
Genitourinary Tract Hemorrhage
Hemodynamic Instability
Hemorrhage
Metabolic Syndrome X
Metrorrhagia
Ovarian Cyst
Polycystic Ovarian Syndrome
Post-Menopausal Symptoms
Postpartum Hemorrhage
Premature Menopause
Primary Ovarian Failure
Reproductive System Disorder
Significant Bleeding
Skin and Skin Structure Infection
Skin Inflammation
Skin Rash
Threatened Abortion
Uterine Contractions
Uterine Cramps

RELATED ICD CODES:
Absence of Menstruation [626.0]
Acne Not Elsewhere Classified [706.1]
Acne Varioliformis [706.0]
Counseling and Instruction in Natural Family Planning to Avoid Pregnancy [V25.04]
Disorder of Menstruation [626]
Dysmenorrhea [625.3]
Encounter for Contraceptive Management [V25]
Encounter for Contraceptive Pill Surveillance [V25.41]
Encounter for Contraceptive Surveillance Not Elsewhere Classified [V25.49]
Encounter for Emergency Contraceptive Counseling and Prescription [V25.03]
Encounter for General Counseling and Advice for Contraceptive Management [V25.0]
Encounter for Implantable Subdermal Contraceptive Surveillance [V25.43]
Encounter for Initiation of Other Contraceptive Measures [V25.02]
Encounter for Insertion of Implantable Subdermal Contraceptive [V25.5]
Encounter for Insertion of Intrauterine Contraceptive Device [V25.11]
Encounter for Insertion of Intrauterine Contraceptive Device- IUD [V25.1]
Encounter for Intrauterine Contraceptive Device Surveillance [V25.42]
Encounter for Other General Counseling and Advice for Contraceptive Management [V25.09]
Encounter for Other Specified Contraceptive Management [V25.8]
Encounter for Prescription of Oral Contraceptives [V25.01]
Encounter for Removal and Reinsertion of Intrauterine Contraceptive Device [V25.13]
Encounter for Surveillance of Previously Prescribed Contraceptive Methods [V25.4]
Encounter for Unspecified Contraceptive Management [V25.9]
Encounter for Unspecified Contraceptive Surveillance [V25.40]
Endometriosis [617]
Endometriosis in Scar [617.6]
Endometriosis Not Elsewhere Classified [617.8]
Endometriosis Not Otherwise Specified [617.9]
Excessive Menstruation [626.2]
Female Genital Symptoms [625]
Hemorrhage Not Otherwise Specified [459.0]
Intestinal Endometriosis [617.5]
Menstrual Disorder Not Otherwise Specified [626.9]
Menstrual Disorders Not Elsewhere Classified [626.8]
Metrorrhagia [626.6]
Other Female Genital Symptoms [625.8]
Other Ovarian Failure [256.39]
Ovarian Dysfunction [256]
Ovarian Dysfunction Not Elsewhere Classified [256.8]
Ovarian Dysfunction Not Otherwise Specified [256.9]
Ovarian Endometriosis [617.1]
Ovarian Failure Not Elsewhere Classified [256.3]
Pelvic Peritoneum Endometriosis [617.3]
Personal History of Contraception [V15.7]
Polycystic Ovaries [256.4]
Premenopausal Menorrhagia [627.0]
Presence of Contraceptive Device [V45.5]
Presence of Intrauterine Contraceptive Device [V45.51]
Presence of Other Contraceptive Device [V45.59]
Presence of Subdermal Contraceptive Implant [V45.52]
Tubal Endometriosis [617.2]
Unspecified Female Genital Symptoms [625.9]
Uterine Endometriosis [617.0]
Vaginal Endometriosis [617.4]
For more information:
Have Rep Call Me Send Information
Educational resources:
No documents.
    
Home  |   Getting Started  |   Site Map  |   Register  |   About  |   Contact Us Privacy Policy  |   Terms of Use  |   Terms of Sale
© 2007-2011 by Physicians Office Resource. All Rights Reserved.